Loria-Kohen Viviana, Espinosa-Salinas Isabel, Marcos-Pasero Helena, Lourenço-Nogueira Thais, Herranz Jesús, Molina Susana, Reglero Guillermo, Ramirez de Molina Ana
Madrid Institute for Advanced Studies in Food, CEI UAM+CSIC, Madrid, Spain.
Madrid Institute for Advanced Studies in Food, CEI UAM+CSIC, Madrid, Spain.
Nutrition. 2016 Apr;32(4):453-60. doi: 10.1016/j.nut.2015.10.013. Epub 2015 Nov 6.
The aim of this study was to assess the effect of a weight loss treatment on obesity- associated variables with respect to the CLOCK and FTO genotypes.
In all, 179 volunteers (78% female) participated in a 12-week calorie-restriction program; hypocaloric diets of between 5442 and 10048 kJ/d were individually prescribed to all participants. Dietetic, anthropometric, and biochemical data were collected at baseline and at the end of the intervention. When treatment was over, five single nucleotide polymorphisms (SNPs) were sought in CLOCK and FTO in all participants who provided consent. Bonferroni-corrected linear regression models were used to examine the influence of interactions of the type genotype × dietetic change on obesity-associated variables.
Variation in the CLOCK and FTO genotypes had no significant influence on the change in obesity-associated variables. The interaction genotype × percentage intake of dietary fat had a significant influence on body mass index (BMI; adjusted P = 0.03). Participants carrying CLOCK rs3749474 (TT + CT) showed a positive association between the change in percentage intake of dietary fat and change in BMI (β = 0.044; 95% confidence interval [CI], 0.0119-0.0769; P = 0.008), whereas participants homozygous for the wild-type allele (CC) showed a negative, although nonsignificant association (β = -0.032; 95% CI, -0.0694 to 0.036; P = 0.077).
The possession of CLOCK rs3749474 may influence the effect of reducing the percentage intake of dietary fat on obesity-associated variables. Participants carrying this SNP might benefit more than others from weight loss treatment involving dietary fat restriction. The treatment of obesity might therefore be customized, depending on the alleles carried.
本研究旨在评估减肥治疗对与生物钟基因(CLOCK)和肥胖相关基因(FTO)基因型相关的肥胖变量的影响。
共有179名志愿者(78%为女性)参与了一项为期12周的热量限制计划;为所有参与者分别制定了每天5442至10048千焦的低热量饮食。在基线和干预结束时收集饮食、人体测量和生化数据。治疗结束后,在所有同意的参与者中寻找生物钟基因和肥胖相关基因中的五个单核苷酸多态性(SNP)。使用Bonferroni校正的线性回归模型来检验基因型×饮食变化类型的相互作用对肥胖相关变量的影响。
生物钟基因和肥胖相关基因的基因型变异对肥胖相关变量的变化没有显著影响。基因型×膳食脂肪摄入量百分比的相互作用对体重指数(BMI;校正P = 0.03)有显著影响。携带生物钟基因rs3749474(TT + CT)的参与者显示膳食脂肪摄入量百分比变化与BMI变化之间呈正相关(β = 0.044;95%置信区间[CI],0.0119 - 0.0769;P = 0.008),而野生型等位基因(CC)纯合的参与者显示呈负相关,尽管不显著(β = -0.032;95% CI,-0.0694至0.036;P = 0.077)。
拥有生物钟基因rs3749474可能会影响降低膳食脂肪摄入量百分比对肥胖相关变量的影响。携带此单核苷酸多态性的参与者可能比其他人从涉及膳食脂肪限制的减肥治疗中受益更多。因此,肥胖治疗可能需要根据携带的等位基因进行定制。